Defense against attaching-and-effacing bacteria requires the sequential generation of interleukin 23 (IL-23) and IL-22 to induce protective mucosal responses. Although CD4 + and NKp46 + innate lymphoid cells (ILCs) are the critical source of IL-22 during infection, the precise source of IL-23 is unclear. We used genetic techniques to deplete mice of specific subsets of classical dendritic cells (cDCs) and analyzed immunity to the attaching-and-effacing pathogen Citrobacter rodentium. We found that the signaling receptor Notch2 controlled the terminal stage of cDC differentiation. Notch2-dependent intestinal CD11b + cDCs were an obligate source of IL-23 required for survival after infection with C. rodentium, but CD103 + cDCs dependent on the transcription factor Batf3 were not. Our results demonstrate a nonredundant function for CD11b + cDCs in the response to pathogens in vivo.
The cytokines interleukin 23 (IL-23) and IL-22 are critical for immune responses that maintain mucosal integrity against infections by attaching-and-effacing bacterial pathogens 1,2 . Isolated lymphoid follicles (ILFs) in the small and large intestine contain dendritic cells (DCs), B cells and innate lymphoid cells (ILCs) that orchestrate protection against those pathogens [2] [3] [4] . During such infections, ILCs produce IL-22, which promotes barrier integrity by inducing the production of antimicrobial peptides, including RegIIIβ and RegIIIγ, by epithelial cells 2, 5, 6 . The importance of IL-22 is indicated by the susceptibility of Il22 −/− mice to the attaching-and-effacing bacterium Citrobacter rodentium, a model for the infection of humans with enteropathogenic and enterohemorrhagic Escherichia coli 2,6,7 .
IL-22-producing ILCs are heterogeneous and include a CD4 + subset 5 and a CD4 − NKp46 + subset 8 . Both subsets express the transcription factor RORγt, which is required for their development 9, 10 . An important unresolved question is the identity of the cells that stimulate ILCs to produce IL-22. ILCs do not directly detect infection by attaching-and-effacing pathogens but instead seem to depend on IL-23 produced by other innate cells for their activation 2, 8 . It has been suggested that in response to C. rodentium, either macrophages or DCs may be the main source of IL-23 (refs. 11,12) . A role for macrophages was proposed on the basis of the greater pathogen burden of mice deficient in the chemokine receptor CX3CR1 (Cx3cr1 −/− mice), as well as the greater susceptibility of CD11c-DTR mice (which, after treatment with diphtheria toxin, are selectively depleted of cells that express diphtheria toxin receptor (DTR) under the control of the promoter of the gene encoding the integrin CD11c) to such infection 12 . Alternatively, a role for classical DCs (cDCs) was proposed on the basis of the greater pathogen burden and lower IL-23 production in mice that lack the lymphotoxin-β receptor (LTβR) in CD11c-expressing cells 11 and by the separate observation that cDCs are the main source of IL-23 after stimulation of Toll-like receptor 5 (ref. 13) .
The opposing conclusions of those studies emphasize the difficulty in distinguishing the roles of macrophages and cDCs in vivo, particularly for studies that rely on depletion methods based on CD11c 14 . Zbtb46 has been identified as a transcription factor expressed in cDCs but not macrophages, monocytes or plasmacytoid DCs (pDCs), and expression of DTR under the control of the Zbtb46 promoter (Zbtb46 DTR ) allows selective depletion of cDCs 15, 16 . Other systems have been developed that also allow selective depletion of individual 9 3 8 VOLUME 14 NUMBER 9 SEPTEMBER 2013 nature immunology A r t i c l e s cDC subsets in vivo [17] [18] [19] [20] . Mice deficient in the transcription factor Batf3 lack the CD8α + cDC subset that is identified by its expression of CD103 in the periphery; as a result, these mice have defective CD8 + T cell responses to several viral pathogens 17, 21 and are susceptible to infection with Toxoplasma gondii 22 . Similarly, mice with selective depletion of pDCs have defects in the production of type I interferon and are susceptible to chronic infection by viruses such as lymphocytic choriomeningitis virus 19, 23 . Thus, studies using systems of selective depletion have identified nonredundant roles for CD8α + cDCs and pDCs but not for the third major subset of DCs, the CD11b + cDCs.
A subset of CD11b + cDCs in vivo expressing the adhesion molecule ESAM undergoes depletion after conditional deletion of the gene encoding the signaling receptor Notch2 (ref. 18) . That study proposed that Notch2 signaling is selectively required for the development of splenic CD11b + ESAM + cDCs and intestinal CD103 + CD11b + cDCs derived from the precursor of the cDC (pre-cDC), analogous to the unique dependence of CD8α + cDCs on Batf3 (ref. 17) . However, CD11b + ESAM − cDCs persist in Notch2-deficient mice, which prompts the question of how those cells are related to CD11b + ESAM + cDCs and whether they provide compensatory functions. Furthermore, although that study suggested that Notch2 specifically regulates the CD11b + branch of cDCs, some evidence indicated a developmental defect in the CD8α + branch as well, although that was not further analyzed 18 . Unexpectedly, mice that lack CD103 + CD11b + cDCs have only 50% less production of IL-17 by T cells stimulated ex vivo, and responses during infection have not been examined to show a specific function for such cells in immunological defense.
Here we demonstrate a selective function for CD11b + cDCs in immunological defense against pathogens. Through the use of several genetic models with selective depletion of various subsets of cDCs in vivo, we found that Notch2-dependent intestinal CD103 + CD11b + cDCs provided nonredundant protection against infection with attaching-and-effacing pathogens, but macrophages or Batf3-dependent CD103 + CD11b − cDCs did not. Notch2-dependent cDCs were required for host survival mediated by the local generation of IL-23-dependent antimicrobial responses early after infection. Developmentally, Notch2 regulated the terminal differentiation of both the CD8α + and CD11b + branches of cDCs, which allowed their subsequent homeostatic population expansion via signaling through LTβR. Our results demonstrate that intestinal CD103 + CD11b + cDCs detect infection with attaching-and-effacing pathogens and secrete IL-23, which is critical for IL-22 production by ILCs and the maintenance of mucosal integrity.
RESULTS cDCs mediate defense against attaching-and-effacing pathogens
The generation of Zbtb46 gfp mice, which express green fluorescent protein (GFP) driven by the Zbtb46 promoter (Zbtb46-GFP), as well as Zbtb46 DTR mice, has allowed the selective visualization and depletion of cDCs, which can help in distinguishing the requirements for cDCs and macrophages in immune responses in vivo 15, 16 . We sought to determine whether expression of Zbtb46-GFP could be used to distinguish cDCs from macrophages in the intestinal lamina propria and mesenteric lymph nodes (MLNs) (Fig. 1a,b) . Among MHCII + CD11c + lamina propria cells, CD103 + CD11b − cells and CD103 + CD11b + cells were uniformly GFP + , consistent with their identity as cDCs. Both CD103 − CD11b + cells and CD103 − CD11b − cells also included a substantial GFP + fraction (Fig. 1a) , in agreement with published studies suggesting that cDCs may also reside in those gates 16, 24, 25 . In contrast, F4/80 + macrophages were present mainly in the MHCII − CD11c + gate and did not express GFP (Fig. 1a) . In the MLNs, migratory cDCs 26, 27 were uniformly GFP + and were mainly in the CD103 + CD11b − and CD103 + CD11b + gates (Fig. 1b) , consistent with the ability of cDCs, but not macrophages, to migrate to the MLNs 28 . Resident cDCs were also uniformly GFP + , but were predominantly in the CD103 − CD11b − or CD103 − CD11b + gate. Thus, expression of Zbtb46 seemed to distinguish cDCs from macrophages in the intestine independently of their expression of the integrins CD103 (α E β 7 ) or CD11b (α M ). Histological assessment of the small intestine of wild-type mice reconstituted with Zbtb46 gfp bone marrow (Zbtb46 gfp chimeras) showed that GFP + cDCs were present in organized lymphoid structures, including Peyer's patches and ILFs, as well as at points of antigen encounter in intestinal villi (Fig. 1c) . In the large intestine, GFP + cDCs were also present in colonic patches, ILFs and surrounding villi (Fig. 1c) .
The results reported above suggested that the administration of diphtheria toxin to Zbtb46 DTR mice should selectively eliminate cDCs but spare macrophages. Indeed, treatment of the Zbtb46 DTR chimeras with diphtheria toxin resulted in a significantly lower frequency of both CD103 + CD11b − cDCs and CD103 + CD11b + cDCs in the lamina propria and the F4/80 − populations of CD103 − CD11b − cDCs and CD103 − CD11b + cDCs, but did not affect F4/80 + macrophages (Fig. 2a,b) . In addition, lymphocytes and ILCs in the lamina propria did not undergo depletion after treatment of Zbtb46 DTR chimeras with diphtheria toxin and did not express Zbtb46-GFP ( Supplementary  Fig. 1a-c) . Thus, we used this system to determine whether cDCs were required for protection against C. rodentium. We found that Zbtb46 DTR chimeras treated with diphtheria toxin were unable to recover after challenge with C. rodentium and died within 8-12 d of infection (Fig. 2c) . In contrast, wild-type mice reconstituted with wild-type bone marrow (wild-type chimeras) and Zbtb46 DTR chimeras not treated with diphtheria toxin survived beyond 15 d; they underwent some weight loss but recovered normal weight by 30 d after infection (Fig. 2c,d ).
To confirm a specific role for cDCs and to investigate a possible role for monocyte-derived cells in protection from C. rodentium, we next analyzed mice deficient in the cytokine Flt3L (Flt3l −/− mice) 29 and mice deficient in the chemokine receptor CCR2 (Ccr2 −/− mice) 30 . Flt3l −/− mice have fewer lamina propria cDCs but maintain normal numbers of macrophages and monocytes 24, 25 . Similar to diphtheria toxin-treated Zbtb46 DTR chimeras, Flt3l −/− mice succumbed to C. rodentium infection after 10-16 d (Fig. 2e,f) . In contrast, Ccr2 −/− mice have a specific defect in the recruitment of monocytes to the intestinal lamina propria but maintain normal populations of cDCs 31 . Although Ccr2 −/− mice underwent more weight loss than did their wild-type (Ccr2 +/+ ) counterparts, only 25% succumbed to infection (Fig. 2e,f) . These results demonstrated that cDCs, rather than macrophages or monocyte-derived cells, were required for early innate defense against C. rodentium, but did not indicate whether a particular cDC subset was required.
Notch2-deficient mice lack CD11b + cDCs in vivo Notch2 is required for the development of the CD11b + ESAM + cDC fraction 18 . However, the specific function of those cells has not been determined in vivo. To characterize how Notch2 signaling influences cDC development, we examined the requirement for Notch2 and its transcriptional partner RBPJ, as well as the γ-secretase complex composed of presenilin 1 (PSEN1) and PSEN2, in the development of splenic CD8α + or CD11b + cDCs (Fig. 3a) . Hematopoietic loss of either Rbpj or Notch2 mediated by Cre recombinase expressed from the hematopoietic compartment-specific promoter Vav1 (Vav1-Cre) resulted in a lower frequency of CD11c + MHCII + cDCs and CD8α + cDCs (identified by expression of the surface marker CD24) and npg elimination of CD11b + ESAM + CD4 + cDCs (also identifiable by expression of the signaltransduction molecule CD172a rather than CD11b; Fig. 3a ). Vav1-Cre-mediated deletion of Psen1 and Psen2 also resulted in a similarly lower frequency of CD11c + MHCII + cDCs and CD8α + cDCs and elimination of ESAM + CD4 + cDCs (Fig. 3a) . These results indicated that deletion of RBPJ affected cDC development through loss of canonical Notch signaling rather than through derepression of genes that are not targets of Notch. Histologically, deletion of Notch2 eliminated the characteristic clusters of CD11b + cDCs in the marginal zone and bridging channels of the spleen 32 , which left a distribution of cDCs loosely scattered throughout the T cell zones and red pulp (Fig. 3b) .
As loss of Notch2 also affects the development of additional hematopoietic lineages 33 , we used Cre expressed from the promoter of the gene encoding CD11c (CD11c-Cre) instead of the Vav1-Cre system to restrict the effect of Notch2 deletion to myeloid lineages for analysis of cDC function during infection in vivo. Deletion of Notch2 by CD11c-Cre (Notch2 cKO ) generated defects in cDC development identical to those that resulted from Vav1-Cre-induced deletion of Notch2 (Fig. 3c,d ) but prevented effects on other hematopoietic lineages (Supplementary Fig. 2 ). Notch2 cKO mice had fewer splenic cDCs than did their Notch2-sufficient counterparts and had no ESAM + CD4 + cDCs (Fig. 3c,d) . A fraction of CD24 + cDCs also expressed ESAM and was dependent on Notch2 signaling (Fig. 3c,d) , which suggested that Notch2 acted in a similar way, although to a different extent, in the development of the CD11b + and CD8α + subsets of cDCs. Notch2-dependent ESAM + cDCs were abundant not only in the spleen but also in the resident cDC fraction in the MLNs (Supplementary Fig. 2a) . Similarly, a small fraction of resident ESAM + , Notch2-dependent cDCs was present in skin-draining lymph nodes ( Supplementary  Fig. 2a) . In contrast, migratory dermis-derived cDCs in skin-draining lymph nodes and peripheral tissue-resident cDCs in the lungs and kidneys were not affected by Notch2 deletion 18 ( Supplementary  Fig. 2a,b) . In the intestinal lamina propria, deletion of Notch2 resulted in a much lower frequency of CD103 + CD11b + cDCs (Fig. 3e) .
In contrast, Batf3 −/− mice selectively lacked the complementary lamina propria CD103 + CD11b − cDC subset (Fig. 3e) but retained normal numbers of CD103 + CD11b + cDCs 34 . Similarly, Notch2 cKO mice had considerably fewer migratory CD103 + CD11b + cDCs in the MLNs, and Batf3 −/− mice had no CD103 + CD11b − cDCs (Fig. 3e) . The development of cryptopatches and ILFs containing CD11c + cDCs and ILCs was unaffected in Notch2 cKO mice ( Fig. 3f and Supplementary Fig. 2d ), consistent with a published report showing that CD11b + DCs are present mainly in the lamina propria and not in ILFs 35 . Thus, Notch2 cKO mice provided an in vivo system for the analysis of CD11b + cDC function in the presence of intact lymphoid structures.
Notch2 controls the terminal differentiation of cDC subsets
Although the role of Notch2 in cDC development is thought to be limited to the CD11b + subset of cDCs 18 , we observed that Notch2 cKO mice also had defects in the CD8α + cDC subset (Fig. 3c,d) . As CD8α expression can be altered by manipulation of the Notch pathway 36 , we used expression of CD24 and the DC marker DEC-205 (CD205) 
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Cx3cr1, we found that CD11b + ESAM + cDCs, which underwent depletion in Notch2 cKO mice, were distinguished from CD11b + ESAM − cDCs on the basis of GFP expression (Fig. 4e, top) . Similarly, two populations were also distinguished on the basis of their expression of GFP and CD4 (Fig. 4e, bottom) . These subsets probably reflected true differences in the maturity of CD11b + cDCs, as Zbtb46, which has intermediate expression in cDC progenitors and is upregulated in mature cDCs 16 , had higher expression in the ESAM + fraction of CD11b + cDCs than in the ESAM − fraction (Fig. 4d,e) . Accordingly, both ESAM + cDCs and ESAM − cDCs developed from wild-type common DC progenitors and pre-DCs in vivo ( Supplementary Fig. 4a,b) , which supported a model in which Notch2 influenced the terminal cDC differentiation of pre-DC-derived cells.
To evaluate the stage at which Notch2 first affected cDC development, we analyzed competitive mixed chimeras generated by reconsititution of wild-type mice with bone marrow from wild-type donors and donors with Vav1-Cre-mediated deletion of Notch2 (Notch2 vav ), in which Notch2 is deleted at an early stage of hematopoietic development (Fig. 4f) . We observed equal competition between wild-type and Notch2 vav progenitors for cells in the lineage-negative (Lin − ) Sca-1 + c-Kit + fraction and up to the pre-DC stage of DC development ( Fig. 4f and Supplementary Fig. 5a ). However, in the mature splenic cDC compartment, wild-type cells outcompeted Notch2 vav cells ( Fig. 4f and Supplementary Fig. 5b ), which indicated that Notch2 first affected development after the pre-DC. We noted this effect in both the CD11b + and CD8α + subset of mature cDCs and, furthermore, in both the ESAM + and ESAM − fraction of each cDC subset. In summary, our analyses of gene expression and competitive bone marrow chimeras indicated that Notch2 acted in the terminal differentiation of CD11b + cDCs and CD8α + cDCs. to identify this subset of cDCs ( Supplementary Fig. 3a) . To assess the transcriptional effects of Notch2, we analyzed gene expression in both CD11b + cDCs and DEC-205 + cDCs from mice with loxPflanked Notch2 alleles (Notch2 f/f mice) and Notch2 cKO mice ( Fig. 4a and Supplementary Fig. 3a ). As expected, we noted substantial differences between Notch2 f/f CD11b + cDCs and Notch2 cKO CD11b + cDCs. In particular, the expression of known Notch targets such as Hes1 and Dtx1 was lower in Notch2 cKO CD11b + cDCs, as was the expression of cDC-specific genes such as Lphn3, Spint1 and Dnase1l3 (Fig. 4a) . Most of the genes regulated by Notch2 in CD11b + cDCs were also regulated by Notch2 in DEC-205 + cDCs (Fig. 4a) . In CD11b + cDCs, Notch2 influenced gene expression in both the ESAM + and ESAM − fractions ( Supplementary Fig. 3b ), which suggested that Notch2 acted early after differentiation of the CD11b + cDC subset from precDCs, before the induction of ESAM expression, and that its actions were not simply restricted to the development of an ESAM + subset. Likewise, in DEC-205 + cDCs, Notch2 regulated the same set of genes in both the ESAM + and ESAM − fractions, which largely overlapped the genes regulated in CD11b + cDCs (Supplementary Fig. 3b) .
Principal-component analysis showed that similar genes were influenced by Notch2 deficiency in CD11b + cDCs and DEC-205 + cDCs. Principal component 1 (PC1) segregated cDCs by lineage subset, which distinguished CD11b + cDCs from DEC-205 + cDCs (Fig. 4b) . In contrast, PC2 segregated both cDC lineages by the presence or absence of Notch2 signaling, which distinguished Notch2-sufficient cDCs from Notch2-deficient cDCs of each lineage (Fig. 4b) . Next we assessed the expression of genes most heavily weighted in PC2 along the developmental pathway from common myeloid progenitor to splenic cDC. Genes with the highest 'loadings' in PC2, which were thus induced by Notch2, had high expression in terminally differentiated cDCs but low expression in DC progenitors (Fig. 4b-d) . Conversely, genes with the most negative 'loadings' in PC2 had high expression in progenitor cells. Through the use of reporter mice with sequence encoding GFP knocked into two such genes, Ccr2 and npg
LTbR mediates the population expansion of Notch2-dependent cDCs As Notch2 signaling controls the terminal differentiation of cDCs in the spleen and intestine, its effects should be subsequent to those of Flt3L signaling, which can be observed in the population expansion of DC progenitors in the bone marrow 37 . To test that hypothesis, we compared the development of Notch2-dependent cDC subsets in wild-type and Flt3l −/− mice ( Supplementary Fig. 6a,b) . As expected, Flt3l −/− mice had a much lower abundance of all subsets of cDCs, including CD11b + ESAM + cDCs. However, treatment of wild-type mice with Flt3L resulted in 25-fold more CD11b + ESAM − cDCs but only 2.5-fold more CD11b + ESAM + cDCs (Supplementary Fig. 6c,d) . Thus, Flt3L was necessary but not sufficient for development of CD11b + ESAM + cDCs, which suggested that Notch2 regulated a step in cDC development subsequent to the actions of Flt3L.
Because the lymphotoxin LTα 1 β 2 is required for the proliferation of splenic CD8 − cDCs located in the marginal zone and bridging channels 38 , we investigated whether signaling via both Notch2 and LTβR selectively influenced the same cDC subset. We compared the development of splenic cDC subsets in wildtype, Notch2 cKO and LTβR-deficient (Ltbr −/− ) mice. Ltbr −/− mice, similar to Notch2 cKO mice, had fewer CD11c + MHCII + cDCs and CD8α + cDCs and considerably fewer ESAM + CD4 + cDCs (Fig. 5a) . Similarly, Nik −/− mice, which are deficient in activation of the noncanonical pathway of the transcription factor NF-κB downstream of LTβR signaling, and Nfkb1 −/− mice, which lack the p105 subunit of NF-κB, showed selective loss of ESAM + cDCs but retained ESAM − cDCs (Supplementary Fig. 7a,b) . We did not observe those defects in mice lacking the costimulatory receptor CD40 (Supplementary Fig. 7a ), a member of the tumor-necrosis factor receptor family that can also activate NF-κB 39 . As Ltbr −/− mice lack lymph nodes and Peyer's patches 40 , we sought to determine whether the loss of ESAM + cDCs in these mice was cell intrinsic 
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A r t i c l e s by analyzing mixed chimeras generated by reconsitution of wildtype mice with wild-type and Ltbr −/− bone marrow. We observed substantial outcompetition of Ltbr −/− bone marrow by wild-type bone marrow in the generation of splenic and MLN-resident CD11b + cDCs (Fig. 5b,c) , as well as outcompetition of Ltbr −/− CD8α + cDCs by wild-type CD8α + cDCs in this setting (Fig. 5b,c) . npg bone marrow (Fig. 5b,c) . Similarly, CD8α + cDCs from either donor also developed equally. These results suggested that Notch2 and LTβR acted along a similar pathway in cDC development. Furthermore, in these mixed chimeras, Notch2 cKO bone marrow did not generate any ESAM + cDCs, whereas Ltbr −/− bone marrow generated a small population of ESAM + cDCs (Fig. 5b) , which suggested that the requirement for Notch2 preceded the requirement for LTβR. In this model, Ltbr −/− cDCs were able to activate Notch2 signaling and progress to an ESAM + subset but were unable to undergo homeostatic expansion, which resulted in diminished fitness relative to that of wild-type cDCs; in contrast, Notch2 cKO cDCs were unable to progress to ESAM + cells or undergo LTα 1 β 2 -mediated population expansion ( Supplementary  Fig. 7c) . Given those results, we sought to determine if LTβR also had a similar role in development of Notch2-dependent CD103 + CD11b + cDCs in the lamina propria. Indeed, in mixed chimeras generated by the reconstitution of wild-type mice with wild-type and Ltbr −/− bone marrow, we noted outcompetition of Ltbr −/− bone marrow by wild-type bone marrow in the production of CD103 + CD11b + cDCs, unlike mice deficient in the receptor for interferon-αβ (Ifnar1 −/− mice), which did not show defects in cDC development (Fig. 5d,e) . Thus, LTβR signaling was required for the population expansion of Notch2-dependent cDC subsets. 
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A nonredundant role for CD11b + cDCs in C. rodentium infection As Notch2 cKO and Batf3 −/− mice lacked CD103 + CD11b + cDCs and CD103 + CD11b − cDCs, respectively, we sought to determine whether either subset was specifically required for host defense against an attaching-and-effacing bacterial pathogen. We compared the survival of Notch2 f/f , Batf3 −/− and Notch2 cKO mice after oral infection with C. rodentium. Although Notch2 f/f and Batf3 −/− mice were resistant, Notch2 cKO mice were highly susceptible to infection, which caused death within 7-10 d (Fig. 6a) . Unlike Notch2 f/f or Batf3 −/− mice, Notch2 cKO mice underwent rapid weight loss after infection, and when killed at day 9, they had significantly greater pathogen burden and shorter colons (Fig. 6b-d and Supplementary Fig. 8a,b) . Colons of Notch2 cKO mice had considerable infiltration of inflammatory cells and crypt elongation, scattered loss of mucosal architecture, and ulceration and coagulation necrosis, unlike those of Notch2 f/f mice (Fig. 6e,f) . The development of Batf3-independent CD8α + cDCs during infection with intracellular pathogens such as Listeria monocytogenes has been shown to occur as a result of compensation by the AP-1 factor Batf2 (ref. 41 ). However, CD103 + CD11b − cDCs were not restored in Batf3 −/− mice during infection with C. rodentium (data not shown), and Batf2 −/− mice survived infection without substantial weight loss (Fig. 6g,h) , which suggested that resistance to this attaching-and-effacing pathogen did not require compensatory development of CD8α + cDCs.
To determine whether CD103 + CD11b + cDCs had to migrate to draining lymph nodes to provide protection against C. rodentium, we studied mice deficient in the transcription factor IRF4 (Irf4 −/− mice) or the chemokine receptor CCR7 (Ccr7 −/− mice) 26, 42 . Irf4 −/− mice have a selective defect in the migration of CD11b + cDCs from tissues to draining lymph nodes 42 . We confirmed that migratory CD103 + CD11b + cDCs were absent from the MLNs of Irf4 −/− mice, whereas lamina propria CD103 + CD11b + cDCs were present but less abundant (Supplementary Fig. 8c ). Irf4 −/− mice survived infection with C. rodentium until at least day 28 (Fig. 6g,h) , which excluded the possibility that early resistance required cDC migration. However, those mice did eventually succumb to C. rodentium by day 42 after infection ( Fig. 6g,h) , perhaps because of defects in antibody responses 2, 43 . Next we analyzed Ccr7 −/− mice, which have a general defect in cDC migration 26 but intact antibody responses. These mice were completely resistant to infection with C. rodentium (Fig. 6g,h) , which suggested that protection against such infection was provided by the local action of CD103 + CD11b + cDCs.
To determine whether the defects in mucosal immunity in Notch2 cKO mice were specific to infection with C. rodentium, we infected these mice with T. gondii. In contrast to Batf3 −/− mice, which are highly susceptible and uniformly succumb by 9 d after infection 22 , Notch2 cKO mice survived infection and were indistinguishable from their wild-type counterparts (Supplementary Fig. 8d) . These results demonstrated that CD103 + CD11b + cDCs were not required for resistance to T. gondii and that the function of Batf3-dependent CD103 + CD11b − cDCs seemed to be unaffected in Notch2 cKO mice.
CD11b + cDCs are not essential for healing mucosal wounds We sought to determine whether the enhanced susceptibility of Notch2 cKO mice to C. rodentium reflected local defects in colonic wound repair 44 rather than defects in pathogen-specific immunological defense. Colonic wound repair involves local prostaglandin production by the cyclooxygenase COX-2 (encoded by Ptgs2), which supports epithelial proliferation required for the resolution of inflammation 45 . We noted that CD103 + CD11b + cDCs and macrophages in the intestine expressed Ptgs2 (Fig. 7a) , which suggested that either cell type may 
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A r t i c l e s be involved in supporting wound repair. We used endoscopy-guided mucosal excision to induce colonic injury and found that Notch2 cKO mice had normal wound repair, as did Notch2 f/f and Batf3 −/− mice, in contrast to Notch2 f/f mice treated with the COX-2 inhibitor NS-398 (Fig. 7b,c) . Inhibition of COX-2 after mucosal excision resulted in failed regeneration of the β-catenin-positive epithelial layer and impaired maintenance of the underlying α-smooth muscle actin-positive muscularis propria layer (Fig. 7d) , as reported before 44 . In contrast, Notch2 f/f , Notch2 cKO and Batf3 −/− mice had normal epithelial regeneration and maintenance of the muscularis propria at day 6 after mucosal excision (Fig. 7e) . Thus, cDCs were not required for the prostaglandin production involved in mucosal healing, which suggested that the susceptibility of Notch2 cKO mice to infection with C. rodentium was not due to any defects in wound repair.
CD11b + cDCs regulate IL-23-dependent mucosal immunity
To determine the basis of the susceptibility of Notch2 cKO mice to infection with C. rodentium, we analyzed differences in gene expression in colonic cells isolated from Notch2 f/f , Batf3 −/− and Notch2 cKO mice 9 d after infection (Fig. 8a) . Overall, for colonic gene expression, the difference between Notch2 cKO mice and Notch2 f/f mice was greater than the difference between Batf3 −/− mice and Notch2 f/f mice ( Fig. 8a and Supplementary Table 1) . Ptgs2 expression was not lower in Notch2 cKO mice 9 d after C. rodentium infection (Fig. 8a,b) , consistent with the intact wound healing noted above (Fig. 7e) . However, Notch2 cKO mice had upregulation of various genes encoding inflammatory molecules, including Il1a, Il1b, Il33 and Ccl3, and substantial downregulation of the genes Reg3b and Reg3g, which encode antimicrobial peptides (Fig. 8a-c) . Notably, among the set of genes shown to be induced by the stimulation of colonic cells with IL-22 ex vivo, only Reg3b, Reg3g
and Mup1 had lower expression in the colons of infected Notch2 cKO mice than in their Notch2 f/f counterparts (Fig. 8c) , which indicated the importance of the molecules encoded by those genes in the defense against attaching-and-effacing pathogens 2 . Genes encoding the antimicrobial peptides S100A8 and S100A9 had higher expression in Notch2 cKO mice than in Notch2 f/f mice (Fig. 8c) , consistent with a published report indicating the insufficiency of S100A8 and S100A9 in the defense against C. rodentium 2 . Consistent with the findings reported above, IL-22 production was much lower in Notch2 cKO mice, but not in Batf3 −/− mice, 9 d after infection with C. rodentium (Fig. 8d) . To eliminate the effect of inflammation on gene expression, we also assessed changes in gene expression at day 4 after infection, a time at which no change in histology, pathogen dissemination, colonic length or death had occurred ( Fig. 8e and Supplementary Fig. 8e,f) . Again, Notch2 cKO mice had lower expression of Il22 and of the IL-22-responsive genes Reg3b and Reg3g (which, as noted above, encode antimicrobial peptides) ( Fig. 8e and Supplementary Table 1) . Accordingly, ILCs isolated from Notch2 cKO mice had lower intracellular expression of IL-22 protein at day 4; however, that effect was 'rescued' by the addition of IL-23 ex vivo (Fig. 8f) , which indicated that the lower IL-22 production was extrinsic of ILCs in Notch2 cKO mice and instead probably resulted from a defect in the stimulation of ILCs. 
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A r t i c l e s was expressed specifically in CD11b + CD103 + cDCs in the steady state and 2 d after infection by C. rodentium, but this transcript was undetectable in macrophages in either setting (Fig. 8g) . In addition, we found that intracellular expression of p40 was undetectable in CD11b + cDCs at steady state but increased substantially after activation (Supplementary Fig. 8g ). The inducible expression of Il12b (encoding p40) was not dependent on the presence of CD8α + cDCs or on the transcription factors Batf, Batf2 or Batf3 ( Supplementary  Fig. 8g,h) . Thus, expression of IL-23 was both inducible after activation and restricted to the CD11b + cDC subset.
To determine whether Notch2-dependent cDCs were the obligate source of IL-23 during infection with C. rodentium, we generated mixed chimeras by reconstituting wild-type mice with Notch2 f/f bone marrow and Il23a −/− bone marrow or with Notch2 cKO bone marrow and Il23a −/− bone marrow and analyzed resistance to C. rodentium. In Notch2 cKO -Il23a −/− mixed chimeras, intestinal CD103 + CD11b + cDCs developed only from the Il23a −/− bone marrow, but all other hematopoietic populations were unaffected in their ability to generate IL-23. The survival of Notch2 f/f -Il23a −/− chimeras after infection by C. rodentium was similar to that of chimeras generated by transplantation of wild-type bone marrow alone; however, the survival of Notch2 cKO -Il23a −/− chimeras was similar to that of chimeras generated with Il23a −/− bone marrow alone, which succumbed to C. rodentium at 7-11 d after infection (Fig. 8h) . The observation that Notch2 cKO -Il23a −/− mixed chimeras were as susceptible to C. rodentium infection as were chimeras generated with Il23a −/− bone marrow alone suggested that Notch2-dependent CD11b + CD103 + cDCs were the critical source of IL-23 required for protection. 
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-/-→ WT 20 25 30 npg DISCUSSION Efforts to distinguish the functions of macrophages and DCs have been limited by the availability of systems for the selective depletion of each lineage in vivo 46 . Genetic models have been generated that have led to the characterization of nonredundant roles for CD8α + cDCs and for pDCs [17] [18] [19] , but a unique role for CD11b + cDCs has not been studied by a selective depletion model in vivo so far, to our knowledge. Here we used the Notch2 dependence of CD11b + cDCs to analyze their role in host defense. We observed that Notch2-dependent CD103 + CD11b + cDCs were required for IL-23 production to protect the host from early susceptibility to infection with C. rodentium, but Batf3-dependent CD103 + CD11b − cDCs were not. That role in innate defense was pathogen specific, as CD103 + CD11b + cDCs were not necessary for resistance to T. gondii or for the healing of intestinal mucosa after injury. These findings settle an unresolved question about the critical source of IL-23 required for driving IL-22-dependent antimicrobial responses to infection with attaching-and-effacing pathogens 2 . As IL-22 also acts in other host-defense processes, such as in chronic inflammatory skin disease 6 , future studies should examine the requirement for CD11b + cDCs in those settings as well.
Given our observation that Notch2 also regulated gene expression in CD8α + cDCs, we investigated whether defects in these cDCs could account for early susceptibility to C. rodentium. However, Batf3 −/− and Batf2 −/− mice showed normal resistance to C. rodentium. We also excluded the possibility of a role for other Notch2-independent cDCs. In the absence of Notch2, some CD11b + cDCs developed in the spleen; likewise, Zbtb46-expressing CD103 − CD11b + cDCs may have also developed in the intestine. However, any 'Notch2-inexperienced' CD11b + cDCs remaining in Notch2 cKO mice were insufficient for IL-23 production and protection against infection with C. rodentium. Notch signaling also regulates development of IL-22-producing ILCs 47,48 , but we found that ILC function was not affected by CD11c-Cre-mediated deletion of Notch2. Nonetheless, this dual role of Notch signaling in defense against infection with attaching-and-effacing pathogens might represent a coordinated immunological strategy involving the intentional expression of Notch ligands in pathogen-responsive cellular niches.
Antibody blockade of LTβR in vivo has also been found to diminish IL-23 production during infection with C. rodentium 49 , and conditional deletion of Ltbr by CD11c-Cre increases susceptibility to this pathogen 11, 50 . In addition, a published study has reported a requirement for LTβR in the homeostasis of CD4 + cDCs in the spleen 38 . Such results would suggest a possible relationship between signaling via Notch2 and signaling via LTβR in cDC differentiation. Indeed, we found that LTβR selectively influenced the development of splenic ESAM + cDCs and intestinal CD103 + CD11b + cDCs, but Flt3L did not. It has been shown that loss of LTβR signaling directly impairs Il23a expression by cDCs 11 . However, our results suggest that LTβR signaling may also control the development of CD103 + CD11b + cDCs, which are a source of IL-23, independently of any effects on Il23a expression.
The tissue-resident CD11b + cDCs critical for early defense against C. rodentium were affected in Zbtb46 DTR , Notch2 cKO and Flt3l −/− mice and thus seemed to derive from pre-cDCs, rather than from monocytes. However, our demonstration that Notch2-dependent CD11b + cDCs were required for IL-23-dependent protection against C. rodentium does not exclude the possibility of contributions from macrophages and monocyte-derived cells. Indeed, monocytes serve a protective role in the eradication of C. rodentium after their recruitment to the lamina propria during later stages of infection 51 . So, whereas cDC-derived IL-23 may be critical early, monocyte-derived cells 31 can produce IL-6 (ref. 52) , which could support CD4 + T cell-derived IL-22 production later during infection 53 . Our observation that Ccr2 −/− mice had diminished mortality relative to that of Notch2 cKO mice, yet still lost weight, is also in agreement with a model in which monocytes are important in immune responses to C. rodentium. Thus, future studies should characterize the nonredundant functions of pre-cDC-derived and monocyte-derived cells in resistance to infection with attaching-and-effacing bacteria.
The role of cDCs in immunological defense has been thought to reside mainly in their ability to prime the responses of CD4 + T cells and CD8 + T cells 54 . Our results presented here, along with the similar requirement for CD8α + cDCs in IL-12 production for early innate protection against T. gondii, demonstrate that both branches of cDCs are also critical for the initiation of innate immunity. These findings may indicate that the DC lineage separated from monocytes and macrophages before the emergence of adaptive immunity and that it has a dedicated role in orchestrating the reactions of the expanding family of ILCs 3 .
METhODS
Methods and any associated references are available in the online version of the paper.
Accession code. GEO: microarray data, GSE45698. 
